|
Ref |
Description |
Final Response |
|
278/19/FOI |
Questions relating to metastatic breast cancer, metastatic lung cancer and metastatic renal cell cancer. |
|
|
279/19/FOI |
ICT major incidents |
|
|
280/19/FOI |
Questions relating to atopic dermatitis and asthma treatments |
|
|
281/19/FOI |
Mental Health Care Coordinators |
281 19 FOI Final Response.doc |
|
282/19/FOI |
Employee health and wellbeing |
|
|
283/19/FOI |
Questions relating to melanoma, Non Squamous Cell Non-small cell lung cancer and Urothelial cancer |
|
|
284/19/FOI |
Breast cancer treatments |
|
|
285/19/FOI |
Money spent on external consultants |
|
|
286/19/FOI |
IPFR requests for penile implants over the last 3 years |
|
|
287/19/FOI |
Questions relating to Haemophilia and Von Willebrand |
|
|
288/19/FOI |
Questions relating to biologics and biosimilar prescribing |
|
|
289/19/FOI |
Number of wards that are empty across BCUHB |
|
|
290/19/FOI |
Questions relating to medical locum usage |
|
|
291/19/FOI |
Questions relating to vacancies and substantive recruitment |
|
|
292/19/FOI |
Research into oncology treatments |
|
|
293/19/FOI |
Sun related presentations at ED / MIU |
|
|
294/19/FOI |
Questions relating to communications |
|
|
295/19/FOI |
Questions relating to GP out of hours staffing |
|
|
296/19/FOI |
Questions relating to treatment with Cannabis based products and Sativex |
|
|
297/19/FOI |
Questions relating to Moelwyn Ward |
|
|
298/19/FOI |
Copies of notes from meetings where it was discussed not to include clear parking information on the website |
|
|
299/19/FOI |
Numbers of acute hospital sites, community hopspitals and primary care centres |
|
|
300/19/FOI |
Gout and bowel cleanser products dispensed |
|
|
301/19/FOI |
Hereditary angioedema and immune thrombocytopenia purpura treatments |
|
|
302/19/FOI |
Sexual health service budget and expenditure |
|
|
303/19/FOI |
Questions relating to Robotic Process Automation |
|
|
304/19/FOI |
Questions relating to consultancy costs and interim appointments |
|
|
305/19/FOI |
Mass Spectrometry testing |
|
|
306/19/FOI |
Questions regarding district nurses |
|
|
307/19/FOI |
Questions relating to interim senior managers |
|
|
308/19/FOI |
Allergy related hospital admissions |
|
|
309/19/FOI |
Awyr Las income |
|
|
310/19/FOI |
Pest control |
|
|
311/19/FOI |
Renal cell carcinoma and Hepatic cell carcinoma |
|
|
312/19/FOI |
Intra-vitreal vials/implants |
|
|
313/19/FOI |
Questions relating to head and neck cancer and colorectal cancer |
|
|
314/19/FOI |
Questions relating to self care renal dialysis and travel costs |
|
|
315/19/FOI |
Clinical systems contract expiry |
|
|
316/19/FOI |
Questions regarding BCUHB and Partners’ Scheme under Part 1 of the Mental Health (Wales) Measure 2010 |
|
|
317/19/FOI |
Questions regarding primary care dental contracts |
|
|
318/19/FOI |
IPFR requests regarding mental health treatment for patients who are deaf |
|
|
319/19/FOI |
Amount spent on abortion provision |
|
|
320/19/FOI |
Rental of specialist bariatiric beds and air mattresses |
|
|
321/19/FOI |
Bowel preparation for colonoscopy |
|
|
322/19/FOI |
Dental practices facing contract reduction |
|
|
323/19/FOI |
Contact details of Medical Device Manager and Medical Engineering Manager |
|
|
324/19/FOI |
Adult social care and commissioning teams |
Withdrawn |
|
325/19/FOI |
External support for reviewing human resources initiatives |
|
|
326/19/FOI |
Questions regarding ophthalmology |
|
|
327/19/FOI |
Number of patients treated with a number of medications |
|
|
328/19/FOI |
Claims pursued for retrospective NHS funded continuing healthcare |
|
|
329/19/FOI |
Orthopaedic patient cost per day |
|
|
330/19/FOI |
Use of risankizumab (Skyrizi) |
|
|
331/19/FOI |
GP practices and video consultations |
|
|
332/19/FOI |
Copy of maternity guidelines |
|
| 333/19/FOI | Theatre systems and devices | 333 19 FOI Final Response.docx |